Projects
Search Serbian, European and international standards. Identify the standard organization, select the standard number or keyword, and complete the search you want. You can also add a standard drafting stage or a committee / national committee that drafted the standard
In vitro diagnostic medical devices — Evaluation of stability of in vitro diagnostic reagents
90.92
Standard to be revised
Cosmetics — Determination of sunscreen UVA photoprotection in vitro
60.60
Standard published
Cosmetics — Determination of sunscreen UVA photoprotection in vitro — Amendment 1
60.60
Standard published
Nanotechnologies — Endotoxin test on nanomaterial samples for in vitro systems — Limulus amebocyte lysate (LAL) test
90.20
Standard under periodical review
Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for saliva — Isolated human DNA
60.60
Standard published
Medical laboratories — Concepts and specifications for the design, development, implementation and use of laboratory-developed tests
60.60
Standard published
In vitro diagnostic medical devices — Single-use containers for the collection of specimens from humans other than blood
90.20
Standard under periodical review
Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for circulating tumour cells (CTCs) in venous whole blood — Part 1: Isolated RNA
60.60
Standard published
Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for circulating tumour cells (CTCs) in venous whole blood — Part 2: Isolated DNA
60.60
Standard published
Molecular in vitro diagnostic examinations — Specifications for pre-examination processes for circulating tumour cells (CTCs) in venous whole blood — Part 3: Preparations for analytical CTC staining
60.60
Standard published
In vitro diagnostic medical devices — Evaluation of stability of in vitro diagnostic reagents
40.60
Close of voting
In vitro diagnostic medical devices — General Guidance for manufacturers of lateral flow immunoassay (LFIA) for rapid diagnostic testing (RDT)
50.00
Final text received or FDIS registered for formal approval
Electronic instructions for use for in vitro diagnostic medical devices — Minimum required information and means of delivery
50.20
Proof sent to secretariat or FDIS ballot initiated: 8 weeks
In vitro diagnostic Next Generation Sequencing (NGS) workflows — Part 1: Human DNA examination
40.00
DIS registered
In vitro diagnostic Next Generation Sequencing (NGS) workflows — Part 2: Human RNA examination
40.00
DIS registered
In vitro diagnostic medical devices — Requirements for determining commutability of certified reference materials used as secondary calibrators or trueness controls
40.20
DIS ballot initiated: 12 weeks
